If you’re not looking at medical captives for your clients, you should. @TrueCaptive
Speaker (Andy Neary) argues that medical captives provide substantial value by helping organizations weather 'bad years' driven by larger and more frequent medical claims. He notes the frequency of bad years has increased (used to be one in seven years, now about one in five) and links rising claim costs to greater access to therapies and high pharmaceutical R&D expenses. Because drug development requires large R&D investments (only a small fraction of candidates succeed), captives are presented as a financing approach that can leverage scale and buying power to afford transformative but costly therapies.
Questions this video answers
About one out of every five years (previously one out of every seven).
He characterizes it as roughly one out of 100 drugs or one out of 1,000 drugs (quoted: 'one out of 100 drugs or 1,000 drugs in their pipeline').
Chapters
More from Andy
If you want producers to succeed faster, help them create a sales message that creates confidence.
Sales isn't a zero-sum game! You can have tough competition and still grab a beer after
Option 1: Meditation, a fast walk, a podcast, and protein. The ultimate morning routine!
How you do one thing is how you do everything. Ill elite producers fuel their body.
